Clark MR - Search Results

1

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.

Isaacs JD, Clark MR, Greenwood J, Waldmann H. Isaacs JD, et al. Among authors: clark mr. J Immunol. 1992 May 15;148(10):3062-71. J Immunol. 1992. PMID: 1578132

2

A humanized monovalent CD3 antibody which can activate homologous complement.

Routledge EG, Lloyd I, Gorman SD, Clark M, Waldmann H. Routledge EG, et al. Eur J Immunol. 1991 Nov;21(11):2717-25. doi: 10.1002/eji.1830211111. Eur J Immunol. 1991. PMID: 1834468

3

A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha.

Brüggemann M, Teale C, Clark M, Bindon C, Waldmann H. Brüggemann M, et al. J Immunol. 1989 May 1;142(9):3145-50. J Immunol. 1989. PMID: 2496159

4

The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies.

Clark M, Bindon C, Dyer M, Friend P, Hale G, Cobbold S, Calne R, Waldmann H. Clark M, et al. Eur J Immunol. 1989 Feb;19(2):381-8. doi: 10.1002/eji.1830190224. Eur J Immunol. 1989. PMID: 2522881

5

Blocking of cytotoxic T cell function by monoclonal antibodies against the CD45 antigen (T200/leukocyte-common antigen).

Tighe H, Clark M, Waldmann H. Tighe H, et al. Transplantation. 1987 Dec;44(6):818-23. doi: 10.1097/00007890-198712000-00020. Transplantation. 1987. PMID: 2962345

6

Reshaping human antibodies for therapy.

Riechmann L, Clark M, Waldmann H, Winter G. Riechmann L, et al. Nature. 1988 Mar 24;332(6162):323-7. doi: 10.1038/332323a0. Nature. 1988. PMID: 3127726

7

The potential of hybrid antibodies secreted by hybrid-hybridomas in tumour therapy.

Clark M, Gilliland L, Waldmann H. Clark M, et al. Int J Cancer Suppl. 1988;2:15-7. doi: 10.1002/ijc.2910410706. Int J Cancer Suppl. 1988. PMID: 3162441

8

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.

Hale G, Clark M, Waldmann H. Hale G, et al. J Immunol. 1985 May;134(5):3056-61. J Immunol. 1985. PMID: 3980990

9

Structural motifs involved in human IgG antibody effector functions.

Greenwood J, Clark M, Waldmann H. Greenwood J, et al. Eur J Immunol. 1993 May;23(5):1098-104. doi: 10.1002/eji.1830230518. Eur J Immunol. 1993. PMID: 8477804

10

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.

Cobbold SP, Hale G, Clark MR, Waldmann H. Cobbold SP, et al. Among authors: clark mr. Prog Clin Biol Res. 1990;333:139-51; discussion 152-4. Prog Clin Biol Res. 1990. PMID: 2308978

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters